Royal Bank of Canada’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9K | Sell |
1,067
-1,093
| -51% | -$11.3K | ﹤0.01% | 6191 |
|
|
2025
Q4 | $26K | Buy |
2,160
+453
| +27% | +$4.85K | ﹤0.01% | 5892 |
|
|
2025
Q3 | $14K | Sell |
1,707
-3,451
| -67% | -$26.8K | ﹤0.01% | 6359 |
|
|
2025
Q2 | $32K | Sell |
5,158
-2,255
| -30% | -$12.9K | ﹤0.01% | 6098 |
|
|
2025
Q1 | $36K | Buy |
7,413
+6,371
| +611% | +$52.7K | ﹤0.01% | 5686 |
|
|
2024
Q4 | $10K | Sell |
1,042
-794
| -43% | -$7.29K | ﹤0.01% | 6342 |
|
|
2024
Q3 | $15K | Sell |
1,836
-1,813
| -50% | -$16.5K | ﹤0.01% | 6198 |
|
|
2024
Q2 | $24K | Buy |
3,649
+2,438
| +201% | +$10.5K | ﹤0.01% | 5986 |
|
|
2024
Q1 | $3K | Sell |
1,211
-23,795
| -95% | -$53.6K | ﹤0.01% | 6585 |
|
|
2023
Q4 | $60K | Sell |
25,006
-52,781
| -68% | -$124K | ﹤0.01% | 5908 |
|
|
2023
Q3 | $264K | Sell |
77,787
-37,568
| -33% | -$208K | ﹤0.01% | 4549 |
|
|
2023
Q2 | $849K | Buy |
115,355
+91,904
| +392% | +$852K | ﹤0.01% | 3514 |
|
|
2023
Q1 | $243K | Buy |
23,451
+3,250
| +16% | +$39.3K | ﹤0.01% | 4454 |
|
|
2022
Q4 | $238K | Buy |
20,201
+17,847
| +758% | +$276K | ﹤0.01% | 4728 |
|
|
2022
Q3 | $50K | Buy |
2,354
+638
| +37% | +$17.8K | ﹤0.01% | 5736 |
|
|
2022
Q2 | $54K | Sell |
1,716
-3,126
| -65% | -$107K | ﹤0.01% | 5678 |
|
|
2022
Q1 | $198K | Sell |
4,842
-12,785
| -73% | -$564K | ﹤0.01% | 5095 |
|
|
2021
Q4 | $767K | Sell |
17,627
-379,190
| -96% | -$17.2M | ﹤0.01% | 4084 |
|
|
2021
Q3 | $19.9M | Buy |
396,817
+38,291
| +11% | +$2.32M | 0.01% | 1347 |
|
|
2021
Q2 | $22.6M | Sell |
358,526
-52,088
| -13% | -$3.35M | 0.01% | 1253 |
|
|
2021
Q1 | $38.2M | Buy |
410,614
+151,941
| +59% | +$15.6M | 0.01% | 838 |
|
|
2020
Q4 | $23.2M | Sell |
258,673
-12,369
| -5% | -$1.14M | 0.01% | 1153 |
|
|
2020
Q3 | $28M | Sell |
271,042
-96,639
| -26% | -$10.4M | 0.01% | 890 |
|
|
2020
Q2 | $29.1M | Sell |
367,681
-37,563
| -9% | -$2.8M | 0.01% | 820 |
|
|
2020
Q1 | $23.4M | Buy |
405,244
+7,344
| +2% | +$423K | 0.01% | 826 |
|
|
2019
Q4 | $21.5M | Sell |
397,900
-42,553
| -10% | -$2.31M | 0.01% | 1120 |
|
|
2019
Q3 | $23M | Sell |
440,453
-39,451
| -8% | -$1.84M | 0.01% | 995 |
|
|
2019
Q2 | $23.2M | Sell |
479,904
-120,608
| -20% | -$5.78M | 0.01% | 992 |
|
|
2019
Q1 | $30.3M | Sell |
600,512
-43,761
| -7% | -$2.58M | 0.01% | 801 |
|
|
2018
Q4 | $38.2M | Sell |
644,273
-303,588
| -32% | -$19.6M | 0.02% | 640 |
|
|
2018
Q3 | $62.4M | Sell |
947,861
-111,059
| -10% | -$6.48M | 0.03% | 497 |
|
|
2018
Q2 | $53.5M | Sell |
1,058,920
-112,395
| -10% | -$5.86M | 0.02% | 530 |
|
|
2018
Q1 | $61.7M | Sell |
1,171,315
-76,314
| -6% | -$3.8M | 0.03% | 497 |
|
|
2017
Q4 | $58M | Buy |
1,247,629
+124,698
| +11% | +$5.25M | 0.03% | 537 |
|
|
2017
Q3 | $45.4M | Buy |
1,122,931
+164,363
| +17% | +$5.95M | 0.02% | 609 |
|
|
2017
Q2 | $32.5M | Buy |
958,568
+19,833
| +2% | +$612K | 0.02% | 754 |
|
|
2017
Q1 | $27.3M | Buy |
938,735
+174,891
| +23% | +$5.32M | 0.01% | 827 |
|
|
2016
Q4 | $25.1M | Buy |
763,844
+398,795
| +109% | +$12M | 0.01% | 901 |
|
|
2016
Q3 | $11.5M | Buy |
365,049
+349,319
| +2,221% | +$10.2M | 0.01% | 1391 |
|
|
2016
Q2 | $442K | Sell |
15,730
-3,261
| -17% | -$128K | ﹤0.01% | 3804 |
|
|
2016
Q1 | $690K | Sell |
18,991
-10,681
| -36% | -$377K | ﹤0.01% | 3377 |
|
|
2015
Q4 | $1.19M | Buy |
29,672
+25,242
| +570% | +$880K | ﹤0.01% | 2973 |
|
|
2015
Q3 | $127K | Buy |
4,430
+932
| +27% | +$30.7K | ﹤0.01% | 4616 |
|
|
2015
Q2 | $116K | Sell |
3,498
-12,902
| -79% | -$400K | ﹤0.01% | 4729 |
|
|
2015
Q1 | $472K | Sell |
16,400
-109
| -0.7% | -$3.13K | ﹤0.01% | 3565 |
|
|
2014
Q4 | $449K | Sell |
16,509
-3
| -0% | -$71 | ﹤0.01% | 3675 |
|
|
2014
Q3 | $352K | Sell |
16,512
-3,363
| -17% | -$77K | ﹤0.01% | 3785 |
|
|
2014
Q2 | $447K | Buy |
19,875
+1,819
| +10% | +$42.4K | ﹤0.01% | 3517 |
|
|
2014
Q1 | $456K | Sell |
18,056
-48,300
| -73% | -$1.22M | ﹤0.01% | 3412 |
|
|
2013
Q4 | $1.53M | Buy |
66,356
+42,706
| +181% | +$890K | ﹤0.01% | 2506 |
|
|
2013
Q3 | $451K | Buy |
23,650
+2,609
| +12% | +$46.6K | ﹤0.01% | 3452 |
|
|
2013
Q2 | $303K | Buy |
+21,041
| New | +$305K | ﹤0.01% | 3571 |
|
Other funds holding EBS
VCM
PCM
VPM
Royal Bank of Canada's EBS Position: Q1 2026 in Review
Royal Bank of Canada reduced its Emergent Biosolutions (EBS) stake by 51% in Q1 2026, selling an estimated $11.3K and leaving 1,067 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #6191.
Royal Bank of Canada first reported a position in EBS in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.4M in Q3 2018. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Royal Bank of Canada held 1,067 shares of Emergent Biosolutions worth $9K as of Q1 2026.
- Royal Bank of Canada sold 1,093 Emergent Biosolutions shares in Q1 2026, an estimated $11.3K.
- Emergent Biosolutions made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6191 holding.
- Royal Bank of Canada first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Emergent Biosolutions position peaked at $62.4M in Q3 2018.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.